why is semaglutide being banned Banned? Compounded "semaglutide" is not FDA-approved

Strain, salt

On April 6, the phase III TRANSCEND study results showed that the MC4R agonist setmelanotide reduced the BMI of these patients by an average of 19.8%, offering a promising new treatment option for this group of patients

The return to baseline weight occurred in an average of 1.7 years

It is estimated that approximately 42% of Americans are affected by obesity, and this condition is closely associated with the development of various chronic health conditions

Competitive Analysis The Glucagon-like Peptide 1 (GLP-1) market is highly competitive, here are some of the top market players, Eli Lilly and Company, Sanofi, Novo-Nordisk A/S, AstraZeneca, Pfizer.Inc, Amgen, Inc., Innovent Biologics, Inc., PegBio Co., Ltd, Sun Pharmaceutical Industries Ltd

This does not mean the compounded substance is itself FDA approved